| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11010849 | Pharmacological Reports | 2018 | 10 Pages |
Abstract
Melatonin and AFMK could improve the anti-tumor effect of gemcitabine in PANC-1 cells presumably through the modulation of apoptotic pathway.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Anna Leja-Szpak, Katarzyna Nawrot-PorÄ
bka, Marta Góralska, Martyna JastrzÄbska, PaweÅ Link-Lenczowski, Joanna Bonior, Piotr Pierzchalski, Jolanta Jaworek,